Baillie Gifford - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2023$14,172
+2.7%
3150.0%0.00%
Q4 2022$13,800
-34.3%
3150.0%0.00%
Q3 2022$21,000
+31.2%
3150.0%0.00%
Q2 2022$16,000
-20.0%
3150.0%0.00%
Q1 2022$20,000
-41.2%
3150.0%0.00%
Q4 2021$34,000
-2.9%
315
-8.2%
0.00%
Q3 2021$35,000
-2.8%
343
-15.1%
0.00%
Q2 2021$36,000
-12.2%
404
-5.2%
0.00%
Q1 2021$41,0004260.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 448,987$28,375,97815.72%
DAFNA Capital Management LLC 251,521$15,896,1274.35%
Casdin Capital, LLC 620,000$39,184,0003.42%
Rock Springs Capital Management LP 2,186,672$138,197,6703.29%
EcoR1 Capital, LLC 1,798,300$113,652,5602.78%
Novo Holdings A/S 448,804$28,364,4132.19%
ORACLE INVESTMENT MANAGEMENT INC 41,377$2,615,0261.93%
SECTORAL ASSET MANAGEMENT INC 136,837$8,648,0981.44%
EMERALD MUTUAL FUND ADVISERS TRUST 413,327$26,122,2661.42%
EMERALD ADVISERS, LLC 496,053$31,350,5501.37%
View complete list of BLUEPRINT MEDICINES CORP shareholders